Novo Seeds co-leads €20 Million Series A Financing in STipe Therapeutics

Date
September 30, 2019
Location
Copenhagen
  • STipe funded through Novo Seeds’ company building efforts
  • First company out of BioInnovation Institute, a new Novo Nordisk Foundation initiative

Novo Seeds, the company creation team of Novo Holdings, announced today that it has co-led the €20 million Series A financing round in STipe Therapeutics (STipe).

Read more…

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH